Clinical Trial Update: An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 clinical study is evaluating the safety and preliminary efficacy of AcNK-Sup003 cell injections for relapsed or refractory B-cell non-Hodgkin l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• AcNK-Sup003 cell injection (AcNK-Sup003)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: B-cell Non-Hodgkin Lymphoma (B-NHL) | EARLY_Phase 1 | Status: RECRUITING